Clinical Trials Directory

Trials / Unknown

UnknownNCT04574934

Effect of Aquatic Therapy on Pulmonary Functions in Patients With Muscular Dystrophy

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
South Valley University · Academic / Other
Sex
All
Age
4 Years – 40 Years
Healthy volunteers
Not accepted

Summary

This study aimed to assess the efficacy of aquatic therapy on pulmonary functions in patients with muscular dystrophy.

Detailed description

Muscular dystrophy (MD) is a group of muscle diseases that results in increasing weakening and breakdown of skeletal muscles over time. The disorders differ in which muscles are primarily affected, the degree of weakness, how fast they worsen, and when symptoms begin. Many people will eventually become unable to walk. Some types are also associated with problems in other organs. The muscular dystrophy group contains thirty different genetic disorders that are usually classified into nine main categories or types. The signs and symptoms consistent with muscular dystrophy are: progressive muscular wasting, poor balance, scoliosis (curvature of the spine and the back), progressive inability to walk, waddling gait, Calf deformation, Limited range of movement,respiratory difficulty, cardiomyopathy and muscle spasms

Conditions

Interventions

TypeNameDescription
OTHERaquatic therapyAquatic therapy refers to water-based treatments or exercises of therapeutic intent, in particular for relaxation, fitness, and physical rehabilitation. Treatments and exercises are performed while floating, partially submerged, or fully submerged in water. Many aquatic therapy procedures require constant attendance by a trained therapist and are performed in a specialized temperature-controlled pool. Rehabilitation commonly focuses on improving the physical function associated with illness, injury, or disability

Timeline

Start date
2020-06-01
Primary completion
2020-10-01
Completion
2020-10-01
First posted
2020-10-05
Last updated
2020-10-05

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04574934. Inclusion in this directory is not an endorsement.